GLORIA BRUN: Open Payments
NPI 1417088154 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,600 in 111 payments from 17 companies in 2025. Trend: 2023 $1,745 · 2024 $1,394 · 2025 $2,600
Food & beverage: $2,572Education: $27
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $504 |
| Vanda Pharmaceuticals Inc. | 19 | $503 |
| Alkermes, Inc. | 12 | $277 |
| E.R. Squibb & Sons, L.L.C. | 11 | $257 |
| ABBVIE INC. | 12 | $248 |
| Axsome Therapeutics, Inc. | 8 | $226 |
| Neurocrine BioSciences, Inc. | 4 | $115 |
| Corium, LLC | 6 | $105 |
| Teva Pharmaceuticals USA, Inc. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
Products named: CAPLYTA, FANAPT, COBENFY, VRAYLAR, Auvelity, LYBALVI, INGREZZA, ARISTADA.
Industry payments across TX — which companies pay providers there.
